Showing results (11-20 of 582) with videos related to
Sort By:
Pageof 59
Journal of Virology|August 30, 2013
The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse modelJoana Rocha-Pereira, Dirk Jochmans, Yannick Debing, et al.Antimicrobial Agents and Chemotherapy|October 23, 2013
Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferonYannick Debing, Suzanne U Emerson, Yijin Wang, et al.Gastroenterology|September 27, 2015
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With RibavirinViet Loan Dao Thi, Yannick Debing, Xianfang Wu, et al.European Journal of Medicinal Chemistry|June 1, 2013
In search of flavivirus inhibitors: evaluation of different tritylated nucleoside analoguesGrégory Chatelain, Yannick Debing, Tine De Burghgraeve, et al.Antiviral Research|July 14, 2023
Establishment of a robust rat hepatitis E virus fecal-oral infection model and validation for antiviral studiesXin Zhang, Niels Cremers, Stijn Hendrickx, et al.Gastroenterology|September 3, 2014
A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipientsYannick Debing, Anett Gisa, Kai Dallmeier, et al.Antiviral Research|March 9, 2013
3',5'Di-O-trityluridine inhibits in vitro flavivirus replicationTine De Burghgraeve, Barbara Selisko, Suzanne Kaptein, et al.Journal of Hepatology|December 3, 2015
Stem cell-derived hepatocytes: A novel model for hepatitis E virus replicationNicky Helsen, Yannick Debing, Jan Paeshuyse, et al.Journal of Hepatology|May 14, 2016
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivityYannick Debing, Christophe Ramière, Kai Dallmeier, et al.Pageof 59